Table 2 Clinical characteristics of patient group
From: Association between opioid use disorder (tramadol) and serum level of interleukin-2
Clinical characteristics | Patient (n = 59) |
|---|---|
Age of onset (years) | 23.03 ± 5.70 |
14–25 years | 40 (67.8%) |
> 25 years | 19 (32.2%) |
Duration (years) | 5.66 ± 2.81 |
Dose (mg/day) | 1243.22 ± 629.9 |
Urine assay | |
50- 200 ng/ml | 17 (28.8%) |
> 200 ng/ml | 42 (71.2%) |